IP Verse

Theravance Biopharma R&D Ip, Llc V. Orbicular Pharmaceutical Technologies Private Limited - 1:23-cv-02843

Explore the details of the Theravance Biopharma R&D Ip, Llc V. Orbicular Pharmaceutical Technologies Private Limited case under case number 1:23-cv-02843 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:23-cv-02843
Filing Date
May 24, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
THERAVANCE BIOPHARMA R&D IP, LLC -
MYLAN SPECIALTY L.P. -
ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

May 24, 2023COMPLAINT against ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED ( Filing and Admin fee $ 402 receipt number ANJDC-14342257), Related Case Selected, filed by THERAVANCE BIOPHARMA R&D IP, LLC, MYLAN IRELAND LIMITED, THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA US, INC., MYLAN SPECIALTY L.P.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(CALMANN, ARNOLD) (Entered: 05/24/2023)PACER Document
May 24, 2023NOTICE of Appearance by KATHERINE ANN ESCANLAR on behalf of MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC. (ESCANLAR, KATHERINE) (Entered: 05/24/2023)PACER Document
May 26, 2023AO120 Patent/Trademark Form filed. (jab) (Entered: 05/26/2023)PACER Document
May 26, 2023SUMMONS ISSUED as to ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jab) (Entered: 05/26/2023)PACER Document
May 31, 2023ACKNOWLEDGMENT OF SERVICE Executed by THERAVANCE BIOPHARMA R&D IP, LLC, MYLAN IRELAND LIMITED, THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA US, INC., MYLAN SPECIALTY L.P.. ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED served on 5/31/2023, answer due 6/21/2023. (CALMANN, ARNOLD) (Entered: 05/31/2023)PACER Document
Jun 6, 2023ANSWER to Complaint by ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED.(VAN BUSKIRK, TEDD) (Entered: 06/06/2023)PACER Document
Jun 6, 2023Corporate Disclosure Statement by ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED identifying Orbicular Pharmaceutical Technologies Private Limited as Corporate Parent.. (VAN BUSKIRK, TEDD) (Entered: 06/06/2023)PACER Document
Jun 6, 2023Order Initial Conference set for 7/19/2023 at 10:30 AM in Camden - Courtroom 3B before Magistrate Judge Ann Marie Donio. Signed by Magistrate Judge Ann Marie Donio on 6/6/2023. (mag) (Entered: 06/06/2023)PACER Document
Jun 22, 2023Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J., Enclosing Proposed Consolidation Order. (Attachments: # 1 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 06/22/2023)PACER Document
Jun 26, 2023CONSOLIDATION ORDER. ORDERED that Civil Action 23-926 and 23-2843 are consolidated for all purposes; ORDERED that all filings going forward shall be filed in the 23-926 Action and that the 23-2843 Action shall be administratively terminated. Signed by Judge Karen M. Williams on 6/23/2023. (dmr) (Entered: 06/26/2023)PACER Document
May 24, 2023Judge Karen M. Williams and Magistrate Judge Ann Marie Donio added. (dmw)PACER Document
May 26, 2023Notice of Judicial Preferences. Click here for the Judge's Individual Procedure Requirements. (jab)PACER Document
Jun 7, 2023TEXT ORDER: The initial scheduling conference on 7/19/2023 shall be, and is hereby, RESCHEDULED to 7/27/2023 at 11:00 A.M. in Courtroom 3B, Mitchell H. Cohen U.S. Courthouse, Fourth and Cooper Streets, Camden, New Jersey. The joint discovery plan shall either be filed on the docket, or alternatively, emailed to the Court at [email protected]. SO ORDERED by Magistrate Judge Ann Marie Donio on 6/7/2023. (slc) (Entered: 06/07/2023)PACER Document
Jun 26, 2023Cases associated: Create association to 1:23-cv-00926-KMW-AMD. (dmr)PACER Document
Jun 26, 2023***Civil Case Terminated. (dmr)PACER Document